Canada markets closed

PFE Jan 2024 25.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.14000.0000 (0.00%)
As of 03:26PM EDT. Market open.
Full screen
Previous Close0.1400
Expire Date2024-01-19
Day's Range0.1400 - 0.1500
Contract RangeN/A
Open Interest18.82k
  • Yahoo Finance

    Next-generation mRNA vaccines will be easier to use: Moderna CEO

    Moderna CEO Stéphane Bancel says the company is working on a vaccine formula and packaging that will make it easier to use mNRA technology.

  • Business Wire

    Pfizer Declares Fourth-Quarter 2023 Dividend

    NEW YORK, October 04, 2023--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.41 fourth-quarter 2023 dividend on the company’s common stock, payable December 4, 2023, to holders of the Common Stock of record at the close of business on November 10, 2023. The fourth-quarter 2023 cash dividend will be the 340th consecutive quarterly dividend paid by Pfizer.

  • Reuters

    US plans shift of Merck COVID treatment to commercial market

    The U.S. government will stop distributing free doses of Merck & Co's COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead. The Administration for Strategic Preparedness and Response (ASPR), a division of the U.S. Department of Health and Human Services, said in a statement posted on its website late last week they anticipate transition of the drug, sold under the brand name Lagevrio, from government-managed to traditional commercial distribution in November. Merck, which developed the drug with Ridgeback Biotherapeutics, said in an emailed statement on Wednesday that it needs an updated letter of authorization from the U.S. Food and Drug Administration to allow it to start selling the drug commercially.